Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(602)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 29, 2024 6:27am
Mr. Pidduck, pps +$40, ANTIVIRALS, please read the science
'from 60,000 feet' view. In the near past an ice core drill sample was retrieved from a glacier in China. Scientists said it contained over 30 viruses and around 25 of them
...more
(70)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Mar 29, 2024 5:34am
RE:RE:Additional revenue sources 2024.
Medipharm Labs said that they are preparing the generic Epidiolex for the US market... or did I misunderstand?
Viva Gold: Multiple High-Grade Gold Hits Includes 90 Meters at 2.0 gpt Gold
posted May 05, 2024 9:00am by
Viva Gold Corp.
-
|
TG2409 (21.3 meters at 5.1 gpt Au) was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40 meters depth). TG2408 (18.3 meters at 4.4 gpt Au). TG2407 (89.9 meters@ 2.0 gpt Au). TG2404 (36.6 Meters @ 3.3 gpt Au). “Many geologists go their whole careers without seeing drill results like these ...read more
(545)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Mar 28, 2024 11:11pm
RE:Additional revenue sources 2024.
alleyesonme, I dont tend to follow the tin foil hat theories but I found this message quite cryptic - "we will provide an update later, we're waiting on one more product approval
...more
(820)
•••
Danno13
X
View Profile
View Bullboard History
Comment by
Danno13
on Mar 28, 2024 10:35pm
RE:RE:RE:One drug approved for Brazil, 2nd one pending approval, plan
Have a good weekend Subaru.
(602)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 28, 2024 9:43pm
RE:RE:One drug approved for Brazil, 2nd one pending approval, plan
CEO Pidduck stated it 'politically correct' when he said our stock is undervalued and don't forget, senior management has around 12% ownership in the company based on number of shares plus
...more
(820)
•••
Danno13
X
View Profile
View Bullboard History
Comment by
Danno13
on Mar 28, 2024 8:22pm
RE:One drug approved for Brazil, 2nd one pending approval, plan
Couldn't agree more.Eventually we will get there.I see this company trading north of the old high back in 2019 $7.39
(602)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 28, 2024 6:31pm
RE:RE:One drug approved for Brazil, 2nd one pending approval, plan
Not the market....IT Virtu Group doing 'wash trading' to manipulate the price and trying to keep in an alogrithm predetermined range. It's a form of free market
...more
(71)
•••
Hopeful123
X
View Profile
View Bullboard History
Comment by
Hopeful123
on Mar 28, 2024 6:30pm
RE:RE:One drug approved for Brazil, 2nd one pending approval, plan
Might be due to kick of trust in mgmt.
(71)
•••
Hopeful123
X
View Profile
View Bullboard History
Comment by
Hopeful123
on Mar 28, 2024 5:14pm
RE:One drug approved for Brazil, 2nd one pending approval, plan
I hear ya but the market is bent on keeping it here.
(602)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 28, 2024 1:54pm
One drug approved for Brazil, 2nd one pending approval, plan
to launch generic Epidiolex in the U.S....all from the CC....this stock should be flying over $2 by now based strictly upon forward looking fundamentals already publicly disclosed. It
...more
(820)
•••
Danno13
X
View Profile
View Bullboard History
Comment by
Danno13
on Mar 28, 2024 1:01pm
RE:Germany legalization
As of now, there are approximately 200,000 to 300,000 medical cannabis patients in Germany. The market has experienced rapid growth, expanding at a rate of 30 percent annually for
...more
(11)
•••
NoRiskNoReward
X
View Profile
View Bullboard History
Post by
NoRiskNoReward
on Mar 28, 2024 12:44pm
Germany legalization
According to this article Germany only had 28,000 medical cannabis patients. They expect that number to grow to 800,000 by 2025. A 3000% increase in a year. I think we will finally see the Stada
...more
(6)
•••
rejaj
X
View Profile
View Bullboard History
Post by
rejaj
on Mar 28, 2024 11:33am
One conference call - much to discuss
The comments related to Labs Q4 and Full Year results have been very interesting. The full spectrum of reactions and emotions are all there as would be expected given the details provided in the
...more
(270)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Mar 28, 2024 11:29am
Additional revenue sources 2024.
Earnings call pidduck said they signed multiple B2B contracts which could lead to 10m annualized with more in the works....dronabinol already at 1.5m this year...this potentially adds 16m annually
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon